Traws Pharma, Inc.
NASDAQ Global MarketTotal Valuation
Traws Pharma, Inc. carries a market capitalization of 5.77M, placing it among publicly traded companies globally.
| Market Cap | 5.77M |
| Enterprise Value | N/A |
Share Statistics
Traws Pharma, Inc. currently has 15.26M shares outstanding.
| Shares Outstanding | 15.26M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Traws Pharma, Inc. trades at a trailing price-to-earnings ratio of 0.49.
| PE Ratio | 0.49 |
| PS Ratio | N/A |
| PB Ratio | 7.61 |
| P/TBV Ratio | -17.16 |
| P/FCF Ratio | -0.59 |
| P/OCF Ratio | -0.59 |
Financial Position
Traws Pharma, Inc. maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.93 |
| Quick Ratio | 0.87 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -364.73 |
| Return on Assets (ROA) | -159.21 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Traws Pharma, Inc.'s stock has declined approximately -87.7785% over the past 52 weeks. The 50-day moving average sits at 0.53, while the 200-day moving average is 1.21.
| Beta (5Y) | N/A |
| 52-Week Price Change | -87.7785% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 1.21 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -21.40M, while operating income came in at -21.54M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -21.54M |
| Pretax Income | -21.57M |
| Net Income | -21.57M |
| EBITDA | -21.40M |
| EBIT | -21.54M |
| Earnings Per Share (EPS) | -1.83 |
Balance Sheet
Total book value stands at 1.69M, with working capital of -712,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 5.02M |
| Total Debt | N/A |
| Net Debt | -5.02M |
| Equity (Book Value) | 1.69M |
| Book Value Per Share | 0.11 |
| Working Capital | -712,000.00 |
Cash Flow
Traws Pharma, Inc. produced -16.85M in operating cash flow over the past twelve months.
| Operating Cash Flow | -16.85M |
| Capital Expenditures | N/A |
| Free Cash Flow | -16.85M |
| FCF Per Share | -1.43 |
Dividends & Yields
The company's payout ratio of -18.81 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | -18.81 |
| Shareholder Yield | -88.43 |
| FCF Yield | -169.69 |
Stock Splits
Traws Pharma, Inc.'s most recent stock split took place on September 23, 2024 with a 25:1 split ratio.
| Last Split Date | 9/23/2024 |
| Split Ratio | 25:1 |
Scores
Traws Pharma, Inc. posts an Altman Z-Score of -107.99, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -107.99 |